Le Lézard
Classified in: Health, Business
Subjects: CALENDAR OF EVENTS, STOCK/OTHER MARKET NEWS, HEALTH, BOARD OF DIRECTORS, MISCELLANEOUS

Extendicare Announces Timing of 2018 Second Quarter Results and Conference Call


MARKHAM, Ontario, June 29, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX:EXE) announced today that it plans to release its financial results for the second quarter of 2018, after market close on Thursday, August 9, 2018. A conference call hosted by Tim Lukenda, President and Chief Executive Officer and Elaine Everson, Vice President and Chief Financial Officer will be held on August 10, 2018, at 10:00 a.m. (ET) to discuss the results.

To participate in the conference call on August 10, 2018, please dial 1-800-806-5484 or 416-340-2217 followed by the passcode 8878249#. The conference call and accompanying slide presentation will also be accessible via webcast at www.extendicare.com under the "Our Investors/Events & Presentations" section. A replay of the call will be available approximately two hours after completion of the live call until midnight on August 24, 2018. To access the rebroadcast dial 1-800-408-3053 or 905-694-9451 followed by the passcode 6481348#.

ABOUT EXTENDICARE
Extendicare is a leading provider of care and services for seniors throughout Canada. Through our network of 120 operated senior care and living centres (67 owned/53 managed), as well as our home health care operations, we are committed to delivering care throughout the health care continuum to meet the needs of a growing seniors' population in Canada. Our qualified and highly trained workforce of 23,700 individuals is dedicated to helping people live better through a commitment to quality service and a passion for what we do.

For further information, contact:
Jillian Fountain
Vice President, Investor Relations
Phone: (905)-470-5534; Fax: (905) 470-4003
Email: [email protected]
www.extendicare.com


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: